Efficiency of tranexamic acid in perioperative blood loss in hip arthroplasty: a systematic literature review and meta-analysis

被引:8
作者
Pinzon-Florez, C. E. [1 ]
Velez Canas, K. M. [2 ]
Diaz Quijano, D. M. [1 ]
机构
[1] Univ La Sabana, Fac Med, Grp Invest Clin, Chia, Cundinamarca, Colombia
[2] Univ Rosario, Fac Med, Programa Anestesiol, Bogota, Colombia
来源
REVISTA ESPANOLA DE ANESTESIOLOGIA Y REANIMACION | 2015年 / 62卷 / 05期
关键词
Tranexamic acid; Hip arthroplasty; Antifibrinolytic; Total blood lass; Allogeneic transfusion;
D O I
10.1016/j.redar.2014.10.002
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Introduction and objective: Tranexamic acid (TXA) is an antifibrinolytic drug used to reduce bleeding in mortality risk situations such as trauma. Our objective was to conduct a systematic literature review to evaluate the effectiveness and safety of TXA in reducing bleeding in hip arthroplasty. Material and methods: A systematic literature review and meta-analysis of primary studies similar to controlled trials was performed. Literature was searched in MEDLINE, Embase, Cochrane, LILACS, SciELO and Google Scholar. The review was proposed and undertaken by 2 reviewers and the inclusion criteria were: a) patients undergoing arthroplasty for primary unilateral hip replacement; b) comparison of a treatment group with TXA to a control group that received a placebo or no treatment at all, and c) outcome measures, total blood loss, number of patients receiving allogeneic transfusion and/or incidence of thromboembolic complications. The search was restricted to studies published from 1966 to June 2013. Results: A total of 16 studies with 246 patients were retrieved for this review. The total blood loss outcome evidenced a weighted mean difference in favor of TXA vs. controls undergoing hip arthroplasty (-0.45 [P<0.001, 95% CI -0.65 to -0.24]). Weighted relative risk was estimated for the allogeneic transfusion requirement outcome, showing a trend in favor the TXA arm, with fewer patients requiring allogeneic transfusion in hip surgery (0.8 [P<0.02, 95% CI 0.57 to 1.11]); however, this trend was not statistically significant. Limitations: There is a noticeable difference in methods for quantifying total blood loss across the studies reviewed. The need for transfusion outcomes are probably not significant taking into account the number of events in the TXA group. Conclusions: TXA can be routinely used to reduce intra- and post-operative blood Loss in primary hip arthroplasty. (C) 2014 Sociedad Espanola de Anestesiologia, Reanimacion y Terapeutica del Dolor. Published by Elsevier Espana, S.L.U. All rights reserved.
引用
收藏
页码:253 / 264
页数:12
相关论文
共 33 条
  • [1] Tranexamic acid, given at the end of the operation, does not reduce postoperative blood loss in hip arthroplasty
    Benoni, G
    Lethagen, S
    Nilsson, P
    Fredin, H
    [J]. ACTA ORTHOPAEDICA SCANDINAVICA, 2000, 71 (03): : 250 - 254
  • [2] Blood conservation with tranexamic acid in total hip arthroplasty - A randomized, double-blind study in 40 primary operations
    Benoni, G
    Fredin, H
    Knebel, R
    Nilsson, P
    [J]. ACTA ORTHOPAEDICA SCANDINAVICA, 2001, 72 (05): : 442 - 448
  • [3] A General Framework for the Evaluation of Clinical Trial Quality
    Berger, Vance W.
    Alperson, Sunny Y.
    [J]. REVIEWS ON RECENT CLINICAL TRIALS, 2009, 4 (02) : 79 - 88
  • [4] An analysis of blood management in patients having a total hip or knee arthroplasty
    Bierbaum, BE
    Callaghan, JJ
    Galante, JO
    Rubash, HE
    Tooms, RE
    Welch, RB
    [J]. JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1999, 81A (01) : 2 - 10
  • [5] Risk of bacterial infection associated with allogeneic blood transfusion among patients undergoing hip fracture repair
    Carson, JL
    Altman, DG
    Duff, A
    Noveck, H
    Weinstein, MP
    Sonnenberg, FA
    Hudson, JI
    Provenzano, G
    [J]. TRANSFUSION, 1999, 39 (07) : 694 - 700
  • [6] Reduction of blood loss with tranexamic acid in primary total hip replacement surgery
    Claeys, M. A.
    Vermeersch, N.
    Haentjens, P.
    [J]. ACTA CHIRURGICA BELGICA, 2007, 107 (04) : 397 - 401
  • [7] Ekback G, 2000, ANESTH ANALG, V91, P1124
  • [8] Bone bleeding during total hip arthroplasty after administration of tranexamic acid
    Garneti, N
    Field, J
    [J]. JOURNAL OF ARTHROPLASTY, 2004, 19 (04) : 488 - 492
  • [9] Hedges L, 1985, STAT METHODS METAANA, P108
  • [10] CONVINCING EVIDENCE FROM CONTROLLED AND UNCONTROLLED STUDIES ON THE LIPID-LOWERING EFFECT OF A STATIN
    Higgins, Julian
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (12):